EPCAM and carcinosarcoma: The data presented here demonstrate that EpCAM is expressed in the majority of carcinosarcomas evaluated (80 %) and that solitomab effectively induced ADCC and significant tumor death in carcinosarcoma cell lines expressing EpCAM that were incubated with PBL.